Tag:
bacteria
Latest Headlines
Latest Headlines
'Hypervirulent' salmonella could overwhelm a vaccine
Researchers in the U.S. and Australia have found that salmonella bacteria have the capacity to overwhelm vaccines.
Eisai co-developing cancer drug fueled by bacteria; U.S. trials launch soon
Tokyo's Anaeropharma Science is launching U.S. clinical trials as early as March for a new stomach cancer drug fueled by bacteria.
Pomp and contamination at commencement?
Tried as they might, researchers from the Johns Hopkins Bloomberg School of Public Health did not succeed in taking the joy out commencement season. Aside from an annual dusting off of Bartlett's
Why is the NDM-1 superbug so hard to kill?
Ever since the superbug NDM-1 stirred headlines around the world, investigators have been trying to zero in on the makeup of the antibiotic-resistant bacteria. Now investigators say that NDM-1 (or
NASA stokes fiery debate over bacterium study
A new publication from NASA claiming that a bacterium was able to survive without phosphorus has provoked a storm of controversy and raised doubts about the accuracy of some of the agency's
Gut microbes could offer new therapeutic platform
The bacteria that thrive in our guts could become the key ingredients for a new generation of treatments that fight everything from life-threatening infections to diabetes, obesity, depression and
Super-resistant soil bacteria can thrive on antibiotics
It turns out that hundreds of bacteria can actually 'eat' antibiotics, according to researchers at Harvard Medical School. The scientific team isolated bacteria in soil and fed them 18 different
People, rainfall, biodiversity breed new diseases
An international team of scientists has identified 335 cases of emerging diseases that erupted between 1940 and 2004, with almost three out of four spurring disease in humans after spreading from
U.S. pipeline bone dry for new antibiotics
Even as the demand for new antibiotics grows, new research programs to advance fresh therapies have been drying up fast. While existing antibiotics steadily weaken against the onslaught of some
Concerns grow as biohazard research field booms
Before the 2001 anthrax  attacks, the U.S. had only two biosafety level 4 (BSL4) labs, which conduct
